Clinical trial allocation in multinational pharmaceutical companies - a qualitative study on influential factors-Reference-Cited by-同舟云学术

Clinical trial allocation in multinational pharmaceutical companies - a qualitative study on influential factors

Published:2017-05-19 Issue:3 Volume:5 Page:e00317
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Dombernowsky Tilde¹^ORCID,Haedersdal Merete¹,Lassen Ulrik²,Thomsen Simon F.¹³

Affiliation:

1. Department of Dermatology; Copenhagen University Hospital Bispebjerg; Bispebjerg Bakke 23, entrance 9 DK-2400 Copenhagen NV Denmark

2. Department of Oncology; Copenhagen University Hospital Rigshospitalet; Blegdamsvej 9, entrance 5073 DK-2100 Copenhagen Ø Denmark

3. Department of Biomedical Sciences; University of Copenhagen; Blegdamsvej 3b DK-2200 Copenhagen N Denmark

Funder

Region Hovedstaden

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Reference8 articles.

1. The qualitative content analysis process;Elo;J Adv Nurs,2008

2. English RA Lebovitz Y Giffin RB 2010 Transforming clinical research in the United States: challenges and opportunities: workshop summary The National Academies Press Washington DC

3. Factors influencing clinical trial site selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study);Gehring;BMJ Open,2013

4. Gossen R 2011 http://rebarinteractive.com/patient-recruitment-business-development/

5. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness;Graneheim;Nurse Educ Today,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerating patient recruitment using social media: Early adopter experience from a good clinical practice-monitored randomized controlled phase I/IIa clinical trial on actinic keratosis;Contemporary Clinical Trials Communications;2024-02

2. Site readiness practices for clinical trials – considerations for CTSA hubs;Journal of Clinical and Translational Science;2023

3. France's competitiveness in global pharmaceutical research: The situation is improving;Therapies;2021-11

4. Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality;Frontiers in Medicine;2020-10-22

5. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations;Trials;2019-12